mechanism 3,582 words KG: lysosomal dysfunction
Contents

Lysosomal Dysfunction in Neurodegeneration

Mechanism Info
Namelysosomal dysfunction
Key Genes/Proteinsamyloid-beta, AMYOTROPHIC LATERAL SCLEROSIS, APOE4, AR, C3, C9orf72
Related Diseasesalpha-synuclein aggregation, ALS, Alzheimer's disease, amyotrophic lateral sclerosis
Related Pathwaysautophagy pathway, Aβ accumulation
Linked Hypotheses2 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (153)

Tau-Independent Microtubule Stabilization via MAP6 Enhanceme
Score: 0.57
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.57
Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.57
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.56
Circadian-Gated Maresin Biosynthesis Amplification
Score: 0.56
Digital Twin-Guided Metabolic Reprogramming
Score: 0.55
Temporal Decoupling via Circadian Clock Reset
Score: 0.54
Lysosomal Membrane Repair Enhancement
Score: 0.54
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Blood-Brain Barrier SPM Shuttle System
Score: 0.53
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.53
Cryptic Exon Silencing Restoration
Score: 0.53
Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
Score: 0.53
Piezoelectric Nanochannel BBB Disruption
Score: 0.52
Vocal Cord Neuroplasticity Stimulation
Score: 0.52
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.51
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.48
Microbiome-Derived Tryptophan Metabolite Neuroprotection
Score: 0.43
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
← Prevpg 7/8Next →

Related Analyses (30)

Does TFEB dysfunction cause neurodegeneration or represent a
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Related Experiments (30)

Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.40

See Also (15)

Neuroimaging for Parkinsonian Syndromes (NCT03872102)
clinical · Pages share 27 hypotheses
China Neurodegeneration Epidemiology
disease · Pages share 139 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 139 hypotheses
Beta-Propeller Protein-Associated Neurodegeneration (BP
disease · Pages share 139 hypotheses

Knowledge Graph (12 edges)

TREM2 p.Q33X mutation causes lysosomal dysfunction
lysosomal dysfunction associated_with carcinoma
TDP-43 activates lysosomal dysfunction
GRN causes lysosomal dysfunction
MAPT causes lysosomal dysfunction
C9orf72 causes lysosomal dysfunction
TBK1 prevents lysosomal dysfunction
C3 activates lysosomal dysfunction
RAC1 activates lysosomal dysfunction
TFEB activates lysosomal dysfunction

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.